UC + CD Treatment Overview

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/23

encourage image

There's no tags or description

Looks like no tags are added yet.

24 Terms

1
New cards

what signifies mild-moderate UC

4-6 stools/day, minimal symptoms

2
New cards

what type of UC can be treated with enemas

left sided disease

3
New cards

which type of UC can be treated with suppositories

proctitis

4
New cards

how to treat extensive UC disease

requires systemic treatment

5
New cards

first line treatment for mild-mod active UC

oral and/or topical ASAs (combo more effective)

6
New cards

what to do if pt is unresponsive to standard dose 5-ASA

high dose mesalamine plus rectal mesalamine OR budesonide

7
New cards

what is considered mod-severe active UC

4-6 stools per day, +/- blood in stool, some systemic symptoms

8
New cards

induction treatment options

systemic corticosteroids, TNF inhibitors, biologics, newer small molecules

9
New cards

new induction and maintenance options for mod-severe UC

TNF inhibitors, anti-integrin, IL12/23 inhibitors, JAK inhibitors, S1P inhibitors

10
New cards

recommendation for mod-severe active UC if infliximab is used

combination therapy with thiopurine

11
New cards

rule with thiopurine treatment for mod-severe active UC

thiopurine monotherapy should NOT be used for induction, only an option for maintenance

12
New cards

MTX use for treatment of UC

should NOT be used for induction or maintenance

13
New cards

what characterizes severe-fulminant UC

6-10 BMs/day, blood present, systemic symptoms, requires inpatient treatment

14
New cards

what to use in severe UC in patients first and if they are unresponsive

parenteral corticosteroids, consider TNF inhibitors or cyclosporine if pts are unresponsive

15
New cards

maintenance of remission for UC

choice depends on what was used to induce remission

no role for steroids

ASAs, TNF inhibitors, biologic, purines, newer small molecule

16
New cards

recommendation for patients who are on a biologic for remission that failed 5-ASA previously

recommend AGAINST continuing 5-ASA

17
New cards

ASA recommendations for treating mild-mod active CD

sulfasalazine marginally effective, mesalamine derivatives have minimal efficacy and are not recommended

18
New cards

other first line options for mild-mod active CD

controlled release budesonide, diet based strategies

19
New cards

treatment for mod-severe active CD

systemic corticosteroids (maybe IV if hospitalized), early biologic or advanced therapy may be beneficial

20
New cards

can use in mod-severe CD patients who are failing immunosuppressive treatment or steroid dependent pts

TNF inhibitors (infliximab preferred)

21
New cards

what makes TNF inhibitors more effective for CD

combination therapy with AZA or maybe MTX

22
New cards

immunomodulator monotherapy not recommended to induce remission but may help to maintain remission once induced

AZA and 6-MP

23
New cards

drugs that should NOT be used for mod-severe CD

cyclosporine, 5-ASA, sulfasalazine

24
New cards

treatment for severe-fulminant CD

parenteral corticosteroids, infliximab

AZA and 6-MP

MTX

TNF inhibitors

anti-integrin (vedolizumab only)

IL12/23 inhibitors

JAK inhibitor